|
2025-03-05 |
2025-03-04 |
S
Sale
|
Burkly Linda
EVP, CHIEF SCIENTIFIC OFFICER
Officer
|
2,891
-4.0%
1.71
USD 4,946
|
2,891
-4.0%
|
1.71
|
USD 4,946
|
|
|
2025-03-05 |
2025-03-04 |
S
Sale
|
O'Neill Gilmore Neil
CEO
Executive Director
|
16,632
-5.3%
1.71
USD 28,452
|
16,632
-5.3%
|
1.71
|
USD 28,452
|
|
|
2025-03-05 |
2025-03-04 |
S
Sale
|
Lucera Erick
EVP, CHIEF FINANCIAL OFFICER
Officer
|
4,109
-3.5%
1.71
USD 7,030
|
4,109
-3.5%
|
1.71
|
USD 7,030
|
|
|
2024-12-05 |
2024-12-03 |
S
Sale
|
O'Neill Gilmore Neil
CEO
Executive Director
|
1,618
-0.5%
2.08
USD 3,361
|
1,618
-0.5%
|
2.08
|
USD 3,361
|
|
|
2024-12-05 |
2024-12-03 |
S
Sale
|
Mei Baisong
EVP, CHIEF MEDICAL OFFICER
Officer
|
541
-0.4%
2.08
USD 1,124
|
541
-0.4%
|
2.08
|
USD 1,124
|
|
|
2024-09-06 |
2024-09-04 |
S
Sale
|
Mei Baisong
EVP, CHIEF MEDICAL OFFICER
Officer
|
518
-0.4%
3.42
USD 1,774
|
518
-0.4%
|
3.42
|
USD 1,774
|
|
|
2024-09-06 |
2024-09-04 |
S
Sale
|
O'Neill Gilmore Neil
CEO
Executive Director
|
1,555
-0.5%
3.42
USD 5,325
|
1,555
-0.5%
|
3.42
|
USD 5,325
|
|
|
2024-07-26 |
2024-07-25 |
S
Sale
|
Burkly Linda
EVP, CHIEF SCIENTIFIC OFFICER
Officer
|
11,886
-14.0%
5.42
USD 64,370
|
11,886
-14.0%
|
5.42
|
USD 64,370
|
|
|
2024-07-22 |
2024-07-19 |
S
Sale
|
Mei Baisong
EVP, CHIEF MEDICAL OFFICER
Officer
|
6,619
-4.7%
5.21
USD 34,456
|
6,619
-4.7%
|
5.21
|
USD 34,456
|
|
|
2024-06-06 |
2024-06-04 |
S
Sale
|
Mei Baisong
EVP, CHIEF MEDICAL OFFICER
Officer
|
511
-0.4%
5.50
USD 2,808
|
511
-0.4%
|
5.50
|
USD 2,808
|
|
|
2024-06-06 |
2024-06-04 |
S
Sale
|
O'Neill Gilmore Neil
CEO
Executive Director
|
12,191
-3.7%
5.50
USD 66,997
|
12,191
-3.7%
|
5.50
|
USD 66,997
|
|
|
2024-05-22 |
2024-05-20 |
S
Sale
|
Lucera Erick
EVP, CHIEF FINANCIAL OFFICER
Officer
|
22,337
-16.1%
5.61
USD 125,404
|
22,337
-16.1%
|
5.61
|
USD 125,404
|
|
|
2024-05-14 |
2024-05-13 |
B
Purchase
|
Hopfield Jessica
Non-Executive Director
|
45,000
+198.2%
5.64
USD 253,868
|
45,000
+198.2%
|
5.64
|
USD 253,868
|
|
|
2024-05-14 |
2024-05-13 |
B
Purchase
|
Hopfield Jessica
Non-Executive Director
|
45,000
+198.2%
5.64
USD 253,868
|
45,000
+198.2%
|
5.64
|
USD 253,868
|
|
|
2024-03-05 |
2024-03-05 |
S
Sale
|
O'Neill Gilmore Neil
CEO
Executive Director
|
77,824
-19.2%
9.42
USD 732,884
|
77,824
-19.2%
|
9.42
|
USD 732,884
|
|
|
2024-03-05 |
2024-03-04 |
S
Sale
|
Mei Baisong
SVP, CHIEF MEDICAL OFFICER
Officer
|
20,327
-12.6%
9.42
USD 191,425
|
20,327
-12.6%
|
9.42
|
USD 191,425
|
|
|
2023-12-07 |
2023-12-05 |
S
Sale
|
Eaton Bruce
EVP, CBO AND CTO
Officer
|
103
-0.1%
10.90
USD 1,122
|
103
-0.1%
|
10.90
|
USD 1,122
|
|
|
2023-11-16 |
2023-11-14 |
S
Sale
|
Eaton Bruce
EVP, CBO AND CTO
Officer
|
695
-0.9%
8.21
USD 5,706
|
695
-0.9%
|
8.21
|
USD 5,706
|
|
|
2023-11-09 |
2023-11-07 |
S
Sale
|
Eaton Bruce
EVP, CBO AND CTO
Officer
|
139
-0.2%
8.40
USD 1,168
|
139
-0.2%
|
8.40
|
USD 1,168
|
|
|
2023-09-07 |
2023-09-06 |
S
Sale
|
Eaton Bruce
EVP, CBO AND CTO
Officer
|
103
-0.1%
8.82
USD 908
|
103
-0.1%
|
8.82
|
USD 908
|
|
|
2023-08-15 |
2023-08-11 |
S
Sale
|
Eaton Bruce
EVP, CBO AND CTO
Officer
|
702
-0.9%
8.59
USD 6,033
|
702
-0.9%
|
8.59
|
USD 6,033
|
|
|
2023-08-10 |
2023-08-08 |
S
Sale
|
Eaton Bruce
EVP, CBO AND CTO
Officer
|
141
-0.2%
8.39
USD 1,183
|
141
-0.2%
|
8.39
|
USD 1,183
|
|
|
2023-07-21 |
2023-07-19 |
S
Sale
|
Mei Baisong
SVP, CHIEF MEDICAL OFFICER
Officer
|
4,317
-5.7%
8.80
USD 37,990
|
4,317
-5.7%
|
8.80
|
USD 37,990
|
|
|
2023-06-07 |
2023-06-05 |
S
Sale
|
Eaton Bruce
EVP, CBO AND CTO
Officer
|
105
-0.1%
9.50
USD 998
|
105
-0.1%
|
9.50
|
USD 998
|
|
|
2023-06-07 |
2023-06-05 |
S
Sale
|
O'Neill Gilmore Neil
CEO
Executive Director
|
6,486
-4.7%
9.50
USD 61,638
|
6,486
-4.7%
|
9.50
|
USD 61,638
|
|
|
2023-05-15 |
2023-05-11 |
S
Sale
|
ROBERTSON MICHELLE
EVP, CHIEF FINANCIAL OFFICER
Officer
|
949
-0.9%
9.87
USD 9,369
|
949
-0.9%
|
9.87
|
USD 9,369
|
|
|
2023-05-15 |
2023-05-11 |
S
Sale
|
Eaton Bruce
EVP, CBO AND CTO
Officer
|
668
-0.9%
9.87
USD 6,594
|
668
-0.9%
|
9.87
|
USD 6,594
|
|
|
2023-05-11 |
2023-05-09 |
S
Sale
|
Eaton Bruce
EVP, CBO AND CTO
Officer
|
135
-0.2%
9.51
USD 1,284
|
135
-0.2%
|
9.51
|
USD 1,284
|
|
|
2023-03-06 |
2023-03-03 |
S
Sale
|
ROBERTSON MICHELLE
EVP, CHIEF FINANCIAL OFFICER
Officer
|
184
-0.2%
8.89
USD 1,636
|
184
-0.2%
|
8.89
|
USD 1,636
|
|
|
2023-03-06 |
2023-03-03 |
S
Sale
|
Eaton Bruce
EVP, CBO AND CTO
Officer
|
101
-0.1%
8.89
USD 898
|
101
-0.1%
|
8.89
|
USD 898
|
|
|
2023-02-15 |
2023-02-13 |
S
Sale
|
Eaton Bruce
EVP, CBO AND CTO
Officer
|
3,307
-5.1%
9.67
USD 31,963
|
3,307
-5.1%
|
9.67
|
USD 31,963
|
|
|
2023-02-15 |
2023-02-13 |
S
Sale
|
ROBERTSON MICHELLE
EVP, CHIEF FINANCIAL OFFICER
Officer
|
4,287
-5.3%
9.67
USD 41,435
|
4,287
-5.3%
|
9.67
|
USD 41,435
|
|
|
2023-02-15 |
2023-02-13 |
S
Sale
|
Shearman Mark S
EVP, CHIEF SCIENTIFIC OFFICER
Officer
|
2,790
-4.1%
9.67
USD 26,966
|
2,790
-4.1%
|
9.67
|
USD 26,966
|
|
|
2023-02-09 |
2023-02-07 |
S
Sale
|
Eaton Bruce
EVP, CBO AND CTO
Officer
|
346
-0.5%
11.10
USD 3,841
|
346
-0.5%
|
11.10
|
USD 3,841
|
|
|
2023-01-12 |
2023-01-10 |
S
Sale
|
ROBERTSON MICHELLE
EVP, CHIEF FINANCIAL OFFICER
Officer
|
1,752
-2.1%
8.16
USD 14,296
|
1,752
-2.1%
|
8.16
|
USD 14,296
|
|
|
2022-12-06 |
2022-12-05 |
S
Sale
|
Eaton Bruce
EVP, CHIEF BUSINESS OFFICER
Officer
|
102
-0.2%
10.23
USD 1,043
|
102
-0.2%
|
10.23
|
USD 1,043
|
|
|
2022-12-06 |
2022-12-05 |
S
Sale
|
ROBERTSON MICHELLE
EVP, CHIEF FINANCIAL OFFICER
Officer
|
193
-0.2%
10.23
USD 1,974
|
193
-0.2%
|
10.23
|
USD 1,974
|
|
|
2022-11-09 |
2022-11-08 |
S
Sale
|
Eaton Bruce
EVP, CHIEF BUSINESS OFFICER
Officer
|
289
-0.4%
11.02
USD 3,185
|
289
-0.4%
|
11.02
|
USD 3,185
|
|
|
2022-09-08 |
2022-09-06 |
S
Sale
|
ROBERTSON MICHELLE
EVP, CHIEF FINANCIAL OFFICER
Officer
|
192
-0.2%
15.01
USD 2,882
|
192
-0.2%
|
15.01
|
USD 2,882
|
|
|
2022-09-08 |
2022-09-06 |
S
Sale
|
Eaton Bruce
EVP, CHIEF BUSINESS OFFICER
Officer
|
101
-0.2%
15.01
USD 1,516
|
101
-0.2%
|
15.01
|
USD 1,516
|
|
|
2022-08-10 |
2022-08-09 |
S
Sale
|
Eaton Bruce
EVP, CHIEF BUSINESS OFFICER
Officer
|
293
-0.4%
18.60
USD 5,449
|
293
-0.4%
|
18.60
|
USD 5,449
|
|
|
2022-06-16 |
2022-06-15 |
S
Sale
|
Shearman Mark S
EVP, CHIEF SCIENTIFIC OFFICER
Officer
|
5,145
-7.0%
10.06
USD 51,745
|
5,145
-7.0%
|
10.06
|
USD 51,745
|
|
|
2022-06-06 |
2022-06-03 |
S
Sale
|
ROBERTSON MICHELLE
EVP, CHIEF FINANCIAL OFFICER
Officer
|
1,527
-1.8%
11.54
USD 17,617
|
1,527
-1.8%
|
11.54
|
USD 17,617
|
|
|
2022-06-06 |
2022-06-03 |
S
Sale
|
Eaton Bruce
EVP, CHIEF BUSINESS OFFICER
Officer
|
1,123
-1.7%
11.54
USD 12,956
|
1,123
-1.7%
|
11.54
|
USD 12,956
|
|
|
2022-05-11 |
2022-05-09 |
S
Sale
|
Eaton Bruce
EVP, CHIEF BUSINESS OFFICER
Officer
|
297
-0.4%
13.11
USD 3,895
|
297
-0.4%
|
13.11
|
USD 3,895
|
|
|
2022-04-04 |
2022-04-01 |
S
Sale
|
Eaton Bruce
EVP, CHIEF BUSINESS OFFICER
Officer
|
1,258
-1.8%
19.64
USD 24,707
|
1,258
-1.8%
|
19.64
|
USD 24,707
|
|
|
2022-03-07 |
2022-03-03 |
S
Sale
|
ROBERTSON MICHELLE
EVP, CHIEF FINANCIAL OFFICER
Officer
|
767
-0.9%
17.33
USD 13,290
|
767
-0.9%
|
17.33
|
USD 13,290
|
|
|
2022-03-07 |
2022-03-03 |
S
Sale
|
Eaton Bruce
EVP, CHIEF BUSINESS OFFICER
Officer
|
403
-0.6%
17.33
USD 6,983
|
403
-0.6%
|
17.33
|
USD 6,983
|
|
|
2022-02-10 |
2022-02-08 |
S
Sale
|
Eaton Bruce
EVP, CHIEF BUSINESS OFFICER
Officer
|
302
-1.0%
17.63
USD 5,323
|
302
-1.0%
|
17.63
|
USD 5,323
|
|
|
2022-01-13 |
2022-01-11 |
S
Sale
|
ROBERTSON MICHELLE
Chief Financial Officer
Officer
|
1,744
-5.3%
25.70
USD 44,821
|
1,744
-5.3%
|
25.70
|
USD 44,821
|
|
|
2022-01-04 |
2022-01-03 |
S
Sale
|
MULLEN JAMES C
CEO
Executive Director
|
18,252
-19.4%
26.95
USD 491,979
|
18,252
-19.4%
|
26.95
|
USD 491,979
|
|
|
2021-11-15 |
2021-11-12 |
S
Sale
|
Michaels Lisa Anne
EVP/Chief Medical Officer
Officer
|
1,568
-7.8%
38.33
USD 60,101
|
1,568
-7.8%
|
38.33
|
USD 60,101
|
|
|
2021-11-10 |
2021-11-09 |
S
Sale
|
Eaton Bruce
EVP, Chief Business Officer
Officer
|
287
-1.0%
40.61
USD 11,655
|
287
-1.0%
|
40.61
|
USD 11,655
|
|
|
2021-10-20 |
2021-10-18 |
S
Sale
|
MULLEN JAMES C
CEO
Executive Director
|
13,805
-19.3%
38.03
USD 525,033
|
13,805
-19.3%
|
38.03
|
USD 525,033
|
|
|
2022-04-04 |
2021-08-09 |
S
Sale
|
Eaton Bruce
EVP, CHIEF BUSINESS OFFICER
Officer
|
287
-0.4%
57.17
USD 16,408
|
287
-0.4%
|
57.17
|
USD 16,408
|
|
|
2021-03-05 |
2021-03-03 |
B
Purchase
|
Hopfield Jessica
Non-Executive Director
|
5,800
+34.3%
45.51
USD 263,970
|
5,800
+34.3%
|
45.51
|
USD 263,970
|
|
|
2021-03-04 |
2021-03-02 |
B
Purchase
|
MULLEN JAMES C
CEO
Executive Director
|
25,000
+250.0%
46.27
USD 1,156,800
|
25,000
+250.0%
|
46.27
|
USD 1,156,800
|
|
|
2021-02-10 |
2021-02-09 |
S
Sale
|
Collins Cynthia
CEO
Officer
|
1,262
-2.8%
66.65
USD 84,112
|
1,262
-2.8%
|
66.65
|
USD 84,112
|
|
|
2021-01-13 |
2021-01-12 |
S
Sale
|
ROBERTSON MICHELLE
Chief Financial Officer
Officer
|
1,568
-7.8%
78.27
USD 122,727
|
1,568
-7.8%
|
78.27
|
USD 122,727
|
|
|
2020-12-17 |
2020-12-15 |
PS
Planned sale
|
Albright Charles
EVP/Chief Scientific Officer
Officer
|
200
-0.8%
64.39
USD 12,878
|
200
-0.8%
|
64.39
|
USD 12,878
|
|
|
2020-12-17 |
2020-12-15 |
PS
Planned sale
|
Albright Charles
EVP/Chief Scientific Officer
Officer
|
4,024
-13.8%
63.84
USD 256,892
|
4,024
-13.8%
|
63.84
|
USD 256,892
|
|
|
2020-12-17 |
2020-12-15 |
PS
Planned sale
|
Albright Charles
EVP/Chief Scientific Officer
Officer
|
5,776
-16.5%
62.74
USD 362,386
|
5,776
-16.5%
|
62.74
|
USD 362,386
|
|
|
2020-12-11 |
2020-12-09 |
PS
Planned sale
|
Albright Charles
EVP/Chief Scientific Officer
Officer
|
10,000
-28.6%
45.00
USD 450,000
|
10,000
-28.6%
|
45.00
|
USD 450,000
|
|
|
2020-12-08 |
2020-12-07 |
PS
Planned sale
|
Albright Charles
EVP/Chief Scientific Officer
Officer
|
20,000
-44.5%
40.02
USD 800,400
|
20,000
-44.5%
|
40.02
|
USD 800,400
|
|
|
2020-11-10 |
2020-11-09 |
S
Sale
|
Albright Charles
EVP/Chief Scientific Officer
Officer
|
228
-0.9%
31.21
USD 7,116
|
228
-0.9%
|
31.21
|
USD 7,116
|
|
|
2020-10-16 |
2020-10-15 |
PS
Planned sale
|
Albright Charles
EVP/Chief Scientific Officer
Officer
|
3,000
-10.7%
31.39
USD 94,170
|
3,000
-10.7%
|
31.39
|
USD 94,170
|
|
|
2020-08-21 |
2020-08-20 |
S
Sale
|
Collins Cynthia
CEO
Executive Director
|
1,976
-4.2%
36.66
USD 72,440
|
1,976
-4.2%
|
36.66
|
USD 72,440
|
|
|
2020-08-19 |
2020-08-17 |
PS
Planned sale
|
Albright Charles
EVP/Chief Scientific Officer
Officer
|
10,000
-26.2%
35.29
USD 352,900
|
10,000
-26.2%
|
35.29
|
USD 352,900
|
|
|
2020-08-10 |
2020-08-07 |
S
Sale
|
Albright Charles
EVP/Chief Scientific Officer
Officer
|
238
-0.8%
34.99
USD 8,328
|
238
-0.8%
|
34.99
|
USD 8,328
|
|
|
2020-08-10 |
2020-08-06 |
PS
Planned sale
|
Albright Charles
EVP/Chief Scientific Officer
Officer
|
10,000
-26.1%
37.47
USD 374,700
|
10,000
-26.1%
|
37.47
|
USD 374,700
|
|
|
2020-07-17 |
2020-07-15 |
PS
Planned sale
|
Albright Charles
EVP/Chief Scientific Officer
Officer
|
3,000
-9.6%
32.22
USD 96,660
|
3,000
-9.6%
|
32.22
|
USD 96,660
|
|
|
2020-05-08 |
2020-05-06 |
S
Sale
|
Albright Charles
EVP/Chief Scientific Officer
Officer
|
151
-0.5%
25.28
USD 3,817
|
151
-0.5%
|
25.28
|
USD 3,817
|
|
|
2020-02-10 |
2020-02-07 |
S
Sale
|
Albright Charles
Chief Scientific Officer
Officer
|
622
-1.9%
26.95
USD 16,763
|
622
-1.9%
|
26.95
|
USD 16,763
|
|
|
2020-02-04 |
2020-02-03 |
S
Sale
|
Albright Charles
Chief Scientific Officer
|
5,549
-21.3%
26.54
USD 147,288
|
5,549
-21.3%
|
26.54
|
USD 147,288
|
|
|
2019-08-21 |
2019-08-19 |
S
Sale
|
Collins Cynthia
CEO
Executive Director
|
5,193
-31.3%
25.83
USD 134,135
|
5,193
-31.3%
|
25.83
|
USD 134,135
|
|
